Neurological conditions need longitudinal data most
Your patients' conditions evolve over months and years — MS relapses, seizure frequency trends, post-stroke recovery trajectories, cognitive decline patterns. The data to track these changes exists across multiple EHRs, imaging centers, and rehab facilities. Glance brings it into one longitudinal view so you can see progression, not just the latest visit.
Medication adherence for AEDs, disease-modifying therapies, and anticoagulants. HCC coding for neurological conditions. Stroke risk factor monitoring. All in one normalized record.
Schedule a Demo All SpecialtiesBuilt for how neurologists practice
Neurological care is longitudinal, complex, and data-intensive. Glance surfaces the patterns that matter across visits, providers, and systems.
Seizure, migraine & symptom trending
Track seizure frequency, migraine logs (triggers, aura, duration, severity, response to treatment), MS relapse intervals, and symptom progression over months and years. When your patients log migraines in the Glance patient app — triggers, severity, what helped — those logs sync directly into the provider view. You see real-time patient-reported data alongside clinical records, not just what was captured at the last visit.
AED & DMT medication adherence
Antiepileptic drug adherence directly predicts seizure control. Disease-modifying therapy adherence determines MS progression. Glance computes PDC from pharmacy claims and flags patients below the 80% threshold before they break through.
Stroke risk factor monitoring
Atrial fibrillation, hypertension, diabetes, hyperlipidemia — your stroke patients have comorbidities managed by other providers. Glance aggregates BP trends, HbA1c, anticoagulation PDC, and lipid panels into one view so secondary prevention gaps don't fall through the cracks.
Neurological HCC coding
Epilepsy (HCC 79), stroke/TIA (HCC 100-103), Parkinson's (HCC 78), MS (HCC 77), ALS (HCC 75), dementia (HCC 51-52) — neurological conditions carry significant HCC weight. Glance flags conditions from prior years that need recapture at annual visits, with estimated RAF impact per patient.
Lab & imaging trending
Drug levels (levetiracetam, valproic acid, carbamazepine), renal function for contrast studies, MRI interval tracking for MS and tumor surveillance. Reference ranges are context-aware — therapeutic drug levels have different targets than standard lab values.
Post-stroke transition tracking
The 7-day post-discharge follow-up is a quality measure and a clinical imperative. Glance tracks TRC compliance, rehab referrals, outpatient follow-up scheduling, and medication reconciliation — connecting to your care coordination team automatically.
Quality measures that matter in neurology
Stroke & TIA secondary prevention
Anticoagulation for A-fib, statin therapy, BP control, antiplatelet therapy. Glance computes compliance rates for each intervention and identifies patients with incomplete secondary prevention.
Epilepsy management quality
Seizure freedom rates, AED adherence, therapeutic drug level monitoring, counseling documentation (driving, pregnancy, SUDEP). Track outcomes across your epilepsy panel.
Cognitive screening & dementia care
Cognitive assessment documentation (MMSE, MoCA), caregiver burden screening, advance care planning, medication review for anticholinergic burden. Dementia HCC codes (51-52) are high-value for risk adjustment.
